• Home
  • Search Results
  • Dietary selenium supplementation modifies breast tumor growth and metastasis.

Dietary selenium supplementation modifies breast tumor growth and metastasis.

International journal of cancer (2013-04-25)
Yu-Chi Chen, K Sandeep Prabhu, Arunangshu Das, Andrea M Mastro

The survival rate for breast cancer drops dramatically once the disease progresses to the metastatic stage. Selenium (Se) is an essential micronutrient credited with having high anticancer and chemopreventive properties. In our study, we investigated if dietary Se supplementation modified breast cancer development in vivo. Three diets supplemented with sodium selenite, methylseleninic acid (MSA) or selenomethionine (SeMet), as well as a Se-deficient and a Se-adequate diet were fed to mice before mammary gland inoculation of 4T1.2 cells. The primary tumor growth, the numbers of cancer cells present in lungs, hearts, livers, kidneys and femurs and several proinflammatory cytokines were measured. We found that inorganic selenite supplementation provided only short-term delay of tumor growth, whereas the two organic SeMet and MSA supplements provided more potent growth inhibition. These diets also affected cancer metastasis differently. Mice fed selenite developed the most extensive metastasis and had an increased incidence of kidney and bone metastasis. On the other hand, mice fed the SeMet diet showed the least amount of cancer growth at metastatic sites. The MSA diet also provided some protection against breast cancer metastasis although the effects were less significant than those of SeMet. The cytokine profiles indicated that serum levels of interlukin-2, interleukin-6, interferon γ and vascular endothelial growth factor were elevated in SeMet-supplemented mice. There was no significant difference in tumor growth and the patterns of metastasis between the Se-deficient and Se-adequate groups. Our data suggest that organic Se supplementation may reduce/delay breast cancer metastasis, while selenite may exacerbate it.

Product Number
Product Description

Sodium selenite, 99%
Sodium selenite, anhydrous, ≥90.0% (RT)
Seleno-L-methionine, ≥98% (TLC), powder
Sodium selenite, γ-irradiated, lyophilized powder, BioXtra, suitable for cell culture
Sodium selenite, BioReagent, suitable for cell culture, ≥98%
Methaneseleninic acid, 95%
Seleno-DL-methionine, ≥99% (TLC)